Tokyo Tape
Sign in
← ReproCELL

Quarterly report · Q2

4978.TEDINET S100S7WW
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥3.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.6bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥242m2023-04-01 → 2023-09-30Cons.Operating income
Operating income−¥90m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥70m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥120m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥70m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥62m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥70m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥61m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥305m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥69m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥61m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥69m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥8.4bnat 2023-09-30Cons.Assets
Total assets¥8.4bnat 2023-03-31Cons.Assets
Total assets¥8.8bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥664mat 2023-09-30Cons.Liabilities
Total liabilities¥781mat 2023-03-31Cons.Liabilities
Net assets / equity¥7.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥7.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.1bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥2.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥58m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥141m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥61m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥46m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥541m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥483m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥485m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥0.712023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.132023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.622022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.822022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.312022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio92.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio90.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-09-30−¥214m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥110m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥174m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment ordinary income2023-04-01 → 2023-09-30¥284m
Reconciling Itemsreconcilingsegment ordinary income2022-04-01 → 2022-09-30−¥286m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥674m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥674m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2022-04-01 → 2022-09-30¥222m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥903m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥903m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2022-04-01 → 2022-09-30¥134m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.6bn
—segment totalsegment ordinary income2022-04-01 → 2022-09-30¥356m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 486
ItemContextValueUnit
Deferred tax liabilitiesPrior1YearInstant23208000JPY
Deferred tax liabilitiesCurrentQuarterInstant38420000JPY
Asset retirement obligations nclPrior1YearInstant7754000JPY
Asset retirement obligations nclCurrentQuarterInstant8902000JPY
Noncurrent liabilitiesPrior1YearInstant30962000JPY
Noncurrent liabilitiesCurrentQuarterInstant47323000JPY
LiabilitiesPrior1YearInstant780626000JPY
LiabilitiesCurrentQuarterInstant663871000JPY
Capital stockPrior1YearInstant2023770000JPY
Capital stockCurrentQuarterInstant2023770000JPY
Capital surplusPrior1YearInstant6081653000JPY
Capital surplusCurrentQuarterInstant6081653000JPY
Retained earningsPrior1YearInstant-515460000JPY
Retained earningsCurrentQuarterInstant-454657000JPY
Treasury stockPrior1YearInstant-916000JPY
Treasury stockCurrentQuarterInstant-916000JPY
Shareholders equityPrior1YearInstant7589047000JPY
Shareholders equityCurrentQuarterInstant7649849000JPY
Valuation difference on available for sale securitiesPrior1YearInstant19318000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant85083000JPY
Foreign currency translation adjustmentPrior1YearInstant-33143000JPY
Foreign currency translation adjustmentCurrentQuarterInstant9509000JPY
Valuation and translation adjustmentsPrior1YearInstant-13824000JPY
Valuation and translation adjustmentsCurrentQuarterInstant94592000JPY
Net assetsPrior1YearInstant7575222000JPY
Net assetsCurrentQuarterInstant7744442000JPY
Liabilities and net assetsPrior1YearInstant8355848000JPY
Liabilities and net assetsCurrentQuarterInstant8408314000JPY
Net sales of finished goods rev oaPrior1YTDDuration635738000JPY
Net sales of finished goods rev oaCurrentYTDDuration686969000JPY
Service revenue rev oaPrior1YTDDuration941018000JPY
Service revenue rev oaCurrentYTDDuration460170000JPY
Net salesPrior1YTDDuration1576757000JPY
Net salesCurrentYTDDuration1147139000JPY
Cost of finished goods soldPrior1YTDDuration440170000JPY
Cost of finished goods soldCurrentYTDDuration423787000JPY
Cost of service operations cosPrior1YTDDuration517107000JPY
Cost of service operations cosCurrentYTDDuration224511000JPY
Cost of salesPrior1YTDDuration957278000JPY
Cost of salesCurrentYTDDuration648299000JPY
Gross profitPrior1YTDDuration619479000JPY
Gross profitCurrentYTDDuration498840000JPY
Research and development expenses sgaPrior1YTDDuration209108000JPY
Research and development expenses sgaCurrentYTDDuration167266000JPY
Other selling general and administrative expenses sgaPrior1YTDDuration500510000JPY
Other selling general and administrative expenses sgaCurrentYTDDuration573138000JPY
Selling general and administrative expensesPrior1YTDDuration709619000JPY
Selling general and administrative expensesCurrentYTDDuration740405000JPY
Operating incomePrior1YTDDuration-90139000JPY
Operating incomeCurrentYTDDuration-241565000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass